Integrated HLA LOH Assay (with Versiti)

About Hematologics

Hematologics is a private, revenue-generating diagnostics company that has established itself as a recognized leader in MRD testing for hematologic cancers. Its core technology is the proprietary ∆N:™ (Difference from Normal) flow cytometry platform, which it integrates with a full suite of services including next-generation sequencing, cytogenetics, and cell sorting. The company serves both clinical and biopharmaceutical clients, providing critical data for patient management and clinical trial support. With a deep scientific team and a continuous focus on assay standardization and integration, Hematologics is positioned at the forefront of precision diagnostics in hematology.

Therapeutic Areas